Articles with public access mandates - Hanna RennertLearn more
Not available anywhere: 6
Autosomal dominant polycystic kidney disease caused by somatic and germline mosaicism
AY Tan, J Blumenfeld, A Michaeel, S Donahue, W Bobb, T Parker, ...
Clinical genetics 87 (4), 373-377, 2015
Mandates: US National Institutes of Health
Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series
D Poster, AD Kistler, F Krauer, JD Blumenfeld, H Rennert, D Weishaupt, ...
American journal of kidney diseases 54 (3), 450-458, 2009
Mandates: Swiss National Science Foundation, US National Institutes of Health
Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal‐dominant polycystic kidney disease
YC Tan, J Blumenfeld, A Michaeel, S Donahue, M Balina, T Parker, ...
Clinical genetics 80 (3), 287-292, 2011
Mandates: US National Institutes of Health
Hemorrhagic cysts and other MR biomarkers for predicting renal dysfunction progression in autosomal dominant polycystic kidney disease
S Riyahi, H Dev, JD Blumenfeld, H Rennert, X Yin, H Attari, I Barash, ...
Journal of Magnetic Resonance Imaging 53 (2), 564-576, 2021
Mandates: US National Institutes of Health
Spleen phenotype in autosomal dominant polycystic kidney disease
X Yin, WK Prince, JD Blumenfeld, W Zhang, S Donahue, WO Bobb, ...
Clinical Radiology 74 (12), 975. e17-975. e24, 2019
Mandates: US National Institutes of Health
Development and validation of a whole genome amplification long-range PCR sequencing method for ADPKD genotyping of low-level DNA samples
G Liu, AY Tan, A Michaeel, J Blumenfeld, S Donahue, W Bobb, T Parker, ...
Gene 550 (1), 131-135, 2014
Mandates: US National Institutes of Health
Available somewhere: 32
Whole-exome sequencing of metastatic cancer and biomarkers of treatment response
H Beltran, K Eng, JM Mosquera, A Sigaras, A Romanel, H Rennert, ...
JAMA oncology 1 (4), 466-474, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions
D Butler, C Mozsary, C Meydan, J Foox, J Rosiene, A Shaiber, D Danko, ...
Nature communications 12 (1), 1660, 2021
Mandates: US National Science Foundation, Bill & Melinda Gates Foundation, US National …
Early introductions and transmission of SARS-CoV-2 variant B. 1.1. 7 in the United States
T Alpert, AF Brito, E Lasek-Nesselquist, J Rothman, AL Valesano, ...
Cell 184 (10), 2595-2604. e13, 2021
Mandates: US National Institutes of Health
Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline
IZ Ben-Dov, YC Tan, P Morozov, PD Wilson, H Rennert, JD Blumenfeld, ...
PloS one 9 (1), e86856, 2014
Mandates: US National Institutes of Health
The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations
L Huang, H Fernandes, H Zia, P Tavassoli, H Rennert, D Pisapia, ...
Journal of the American Medical Informatics Association 24 (3), 513-519, 2017
Mandates: US National Science Foundation, US National Institutes of Health
Evaluation of prostate cancer characteristics in four populations worldwide
CM Zeigler-Johnson, H Rennert, RD Mittal, M Jalloh, R Sachdeva, ...
The Canadian journal of urology 15 (3), 4056, 2008
Mandates: US National Institutes of Health
Autosomal dominant polycystic kidney disease: genetics, mutations and microRNAs
YC Tan, J Blumenfeld, H Rennert
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (10 …, 2011
Mandates: US National Institutes of Health
Shotgun transcriptome and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions
DJ Butler, C Mozsary, C Meydan, D Danko, J Foox, J Rosiene, A Shaiber, ...
BioRxiv, 2020
Mandates: US National Science Foundation, Bill & Melinda Gates Foundation, US National …
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care
H Rennert, K Eng, T Zhang, A Tan, J Xiang, A Romanel, R Kim, W Tam, ...
NPJ genomic medicine 1 (1), 1-11, 2016
Mandates: US National Science Foundation, US National Institutes of Health, Damon …
Molecular diagnosis of autosomal dominant polycystic kidney disease using next-generation sequencing
AY Tan, A Michaeel, G Liu, O Elemento, J Blumenfeld, S Donahue, ...
The Journal of Molecular Diagnostics 16 (2), 216-228, 2014
Mandates: US National Institutes of Health
Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease
YC Tan, JD Blumenfeld, R Anghel, S Donahue, R Belenkaya, M Balina, ...
Human mutation 30 (2), 264-273, 2009
Mandates: US National Institutes of Health
A novel long-range PCR sequencing method for genetic analysis of the entire PKD1 gene
YC Tan, A Michaeel, J Blumenfeld, S Donahue, T Parker, D Levine, ...
The Journal of Molecular Diagnostics 14 (4), 305-313, 2012
Mandates: US National Institutes of Health
Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations
JA Kim, JD Blumenfeld, S Chhabra, SP Dutruel, ND Thimmappa, ...
Radiology 280 (3), 762-770, 2016
Mandates: US National Institutes of Health
Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence
J Ahn, AS Kibel, JY Park, TR Rebbeck, H Rennert, JL Stanford, ...
Clinical Cancer Research 17 (5), 1075-1081, 2011
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program